Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MorphoSys

Explore full profile

Biotechnology company focused on the research and development of fully human antibodies

Planegg, GermanyFounded 1992Biotech & Life Sciences
Valuation $2.72B Market cap · 2026
Revenue $262M Latest reported FY

At a glance

Founded
1992
Headquarters
Planegg, Germany
Listing
IPO 2018
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Novartis pays Antares Therapeutics $105M to hunt new cancer drugs Jun 25, 2026

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A4 investors entered at this stage

Series B and later4 investors entered at this stage

  • Max Planck Society
  • Max Planck Innovation
  • Max Planck Institute for Biological Intelligence
  • Max Planck Institute of Biochemistry

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
8 countries with
team presence
🇩🇪 Germany79.2%
🇺🇸 United States16.8%
🇨🇭 Switzerland1.8%
🇦🇷 Argentina0.6%
🇮🇳 India0.6%
Top 5 of 8 shown
Web traffic by country
450 monthly visits
across markets
🇺🇸 United States66.7%
🇬🇪 Georgia22.2%
Top 2 markets shown

Patents

Estimated portfolio value
$321M

152 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where MorphoSys was the backer or acquirer, 2010–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across MorphoSys's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        MorphoSys's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about MorphoSys on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See MorphoSys on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles